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A quick and reliable estimate of extended high-frequency hearing
Garreth Prendergasta, Mark Hymersb and Amy Leea
aManchester Centre for Audiology and Deafness, School of Health Sciences, University of Manchester, Manchester, UK; bYork Neuroimaging
Centre, University of York, York, UK
ABSTRACT
Objective: To encourage researchers to perform high-frequency threshold estimation using a technique
outlined by Rieke and colleagues, described as fixed-level frequency threshold estimation. Their method
used a Bekesy-style roving tone to estimate the highest audible frequency of a listener. The tone was
fixed in its intensity (SPL) and changed in frequency as the participant indicated whether they could per-
ceive the tone, or not. This was developed specifically for ototoxicity monitoring in the extended high-fre-
quency region. Rieke and colleagues established that this approach to measuring hearing thresholds is
both fast and reliable.
Design: The current article extends this approach to using a simple PC-soundcard-transducer setup and
the method of limits to rapidly establish the highest audible frequency of a listener.
Study sample: 24 listeners performed standard and fixed-level audiometry in the extended high-fre-
quency range.
Results: The method described is rapid and reliable and a single summary metric is obtained for
each listener.
Conclusions: The advantage of the described approach over standard pure-tone audiometry in the
extended high-frequency range is the time taken, the ability to avoid missing data points and the risk of
distortions or electrical noise when close to maximal system output.
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Introduction
Routine investigations of human hearing test less than half the
total range of the auditory system. Standard clinical audiometric
testing goes up to 8000Hz (British Society of Audiology 2011)
and it is often assumed that there is little value in assessing the
extended high-frequency (EHF) hearing of listeners. While this
may currently be true for routine clinical investigations, there
has recently been much interest in measuring these responses in
basic research studies in order to establish whether EHF hearing
can provide any new insights into normal and abnormal auditory
function. One particular area where this is close to becoming
common-place is in the the cochlear synaptopathy literature and,
more generally, work which investigates sub-clinical listening dif-
ficulties. Cochlear synaptopathy (sometimes referred to as
“hidden hearing loss”) describes a loss of cochlear synapses
which leads to a loss of information ascending the auditory
nerve, despite normal audiometric function. Cochlear synaptop-
athy occurs as a result of ageing and noise exposure and many
studies have recorded EHF thresholds in their cohorts to estab-
lish whether this region of cochlear function might be a proxy
for damage to the auditory system and may be able to predict
the existence of, or likely development of, changes to auditory
physiology in the standard range (Liberman et al. 2016;
Prendergast, Guest, et al. 2017; Bramhall et al. 2017; Guest et al.
2017; Grose, Buss, and Hall 2017).
Often, the assumption is that there is little direct value of
hearing in the EHF range, though evaluating hearing sensitivity
in this range may be a reliable proxy for other sub-clinical
changes to audition. Despite this, there is evidence that informa-
tion from the EHF range can be used directly by listeners.
Motlagh Zadeh et al. (2019) reported that the presence of acous-
tic information above 8000Hz enhanced speech perception in
noise and Monson et al. (2019) provided evidence that EHFs are
able to assist a listener in performing auditory segregation.
One area in which there has been a clear clinical utility for
EHF thresholds is in the administration of ototoxic drugs for
cancer treatment. A number of treatment pathways rely on drugs
which are known to cause damage to cochlear function; typically
the platinum chemotherapeutic compounds cisplatin and carbo-
platin (Kennedy et al. 1990; Schweitzer 1993). In addition, ami-
noglycosides, typically used to treat infection, have been found
to have ototoxic effects (Matz 1993). These ototoxic changes typ-
ically manifest initially as changes to audiometric sensitivity in
the EHF range (Fausti et al. 1999). Monitoring hearing is a
necessary precaution to take in patients undergoing treatment
for cancer but must compete against monitoring and treatment
for other, potentially more serious, co-morbidities which under-
standably take priority over audiometric testing. Therefore there
is real value in being able to evaluate the EHFs rapidly and reli-
ably in this cohort in order to monitor any longitudinal changes
to audiometric sensitivity in the EHF range.
Fausti et al. (1999) outlined an approach in which a range of
frequencies could be identified at an initial hearing screen which
would remove the testing of needless frequencies at later
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appointments and still allow monitoring of the EHF hearing
capabilities of the patient. Rieke et al. (2017) went further and
developed a test for hearing which would longitudinally allow
monitoring of the highest audible frequency in around 30-sec-
onds. The test involved playing a sound to patients at a fixed
sound intensity and roving the frequency based on whether the
patient could hear the sound or not. The method was demon-
strated to be as reliable as standard fixed-frequency audiometry
(a method which we will refer to throughout this manuscript as
PTA; pure tone audiometry), yet was able to establish the highest
audible frequency in around a tenth of the time. This fixed-level
frequency threshold (FLFT; the alternative method where inten-
sity is fixed and frequency roves) measure could also potentially
be used to quantify EHF hearing capabilities in basic
research studies.
It is clear that there is currently much appetite in basic
research studies for considering the role of EHF hearing in our
understanding of healthy and impaired auditory function
(Hunter et al. 2020). However when conducting these measure-
ments using the standard PTA methodology there are a number
of issues, not encountered when performing audiometry in the
conventional range, which must be considered and mitigated.
The first is the choice of which frequencies to test at, the second
is the issue of missing data points and the third is the risk of
encountering artefacts when requiring very high outputs from
the hardware being used. Some basic research studies perform
testing at a limited number of EHFs (Prendergast, Guest, et al.
2017; Prendergast, Millman, et al. 2017; Guest et al. 2017), and
the estimate of how good a listeners’ EHF hearing is could be
critically dependent on the specific frequencies measured. Other
studies (Liberman et al. 2016; Bramhall et al. 2017) perform test-
ing at a range of EHFs but it can be difficult to combine these
into a summary metric due to the presence of missing data
points. When testing people over the age of 40-, or even 30-years
of age, the likelihood of observing no measurable threshold at
16 kHz increases dramatically and so the information available
with which to stratify listeners based on their EHF thresholds
becomes reduced. Finally, the maximum output of audiometers
is around 90 and 75 dB HL at 14,000 and 16,000Hz, respectively,
which corresponds to 123.5 and 120.5 dB sound pressure level
(SPL), assuming the use of HDA 300 supra-aural transducers
and an Interacoustics Equinox 2.0 audiometer. Such high inten-
sities at these frequencies place severe demands on the hardware
and such systems should be thoroughly and regularly checked
for artefacts. It is difficult for a researcher or audiologist to check
the hardware by listening to the sounds as this would involve
the risk of injurious noise exposure. It is possible that low-fre-
quency electrical noise or transducer artefact is audible at high
output levels and mitigating this risk by monitoring the outputs
can be time-consuming.
Rieke et al. (2017) discuss the suitability of their FLFT
method for evaluating hearing thresholds in the normal-hearing
population for the purpose of basic research studies. Here we
adapt their method into a standard psychophysics framework
which requires no more than a PC, soundcard and headphones
to run. We evaluate a number of summary statistics to demon-
strate the suitability of the approach for measuring the EHF
thresholds of a cohort. The specific SPL chosen can be made
appropriate for the age range and hearing profiles being studied,
but the main advantages are speed of acquisition, the ability to
eliminate missing data points and to ensure that maximal hard-
ware outputs are not required. It is our view that all basic and
translational research studies interested in measuring EHF
hearing can benefit from using the FLFT approach rather than
the routine PTA method of evaluating hearing sensitivity at indi-
vidual frequencies.
Methods
Participants
Twenty-four listeners were tested (16 males) with a mean age of
27.25 years (SD ¼ 5.53, range ¼ 22–39 years). Recruitment crite-
ria required participants to be aged 18–50 years and to be fluent
in written and spoken English in order to be able to understand
the written materials, ask any questions and provide informed
written consent. Participants were not screened for their hearing
profile, although all participants satisfied the common criterion
for clinically normal hearing and had thresholds of 20 dB HL or
better at all frequencies below 8000Hz.
Standard pure tone audiometry
Standard range pure tone audiometry was performed for the
right ear at octave frequencies between 250 and 8000Hz in
accordance with the British Society of Audiology (2011) recom-
mended procedure. Thresholds were measured using a Kamplex
KC 50 clinical audiometer coupled to TDH-39 supra-aural head-
phones, with MX41 cushions. EHF frequency audiometry was
also performed in the right ear using the same audiometer
coupled to Sennheiser HDA 300 circum-aural headphones.
Thresholds were established using the same technique as for fre-
quencies in the standard range. Thresholds were measured at
10,000, 12,000, 15,000, and 16,000Hz using pure tones (the tone
at 15,000Hz was actually 15102Hz, but will be referred to as
15,000Hz for ease).
FLFT estimation
FLFTs were measured using a Creative E-MU 0202 USB sound-
card and Sennheiser HDA 200 circum-aural headphones,
designed for high-frequency audiometry. The sound stimulus
was a pure-tone which was varied adaptively in frequency whilst
remaining fixed in sound level (SPL). Sounds were converted
from digital to analogue at a sample rate of 48,000Hz using 24-
bit depth. A three-alternative forced-choice procedure was used,
with a two-down, one-up staircase adaptively setting the stimulus
level. Figure 1 provides a schematic overview of a single trial and
demonstrates the visual cues given over time (panel A) along
with a descriptor of what happens after a correct and incorrect
response (panel B). Only a single interval of the three contained
a physical stimulus and participants selected which one using a
keyboard. The frequency of the tone for the next stimulus was
then increased or decreased based on the staircase criteria shown
in panel B of Figure 1. Stimuli were 220ms in duration (includ-
ing 10-ms raised-cosine ramps) and there was an inter-stimulus
interval of 500ms between each of the 3 tones. The three inter-
vals were visually cued and participants were required to select
the one interval which contained a tone by pressing a button on
the keyboard. Stimulus level was fixed at either 40, or 70 dB SPL.
For the 40 dB SPL condition, the starting frequency was 8000Hz
and for the 70 dB SPL condition, the starting frequency of the
tone was 16,000Hz. The step size was 1000Hz for the first 4
reversals and this was reduced to 250Hz for the final 10 rever-
sals. FLFTs were calculated by averaging the tone frequency of
the final 10 reversals from a single run. Thresholds were
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estimated twice at each SPL, with conditions presented in a
pseudo-random order. The output measure for each individual
consisted of two average frequencies; one for the 40 dB SPL con-
dition and one for the 70 dB SPL condition.
Analysis
The main analysis was a correlation between FLFTs and thresh-
olds measured using the standard PTA approach. This analysis
allows quantification of the extent to which the different FLFT
measures agree with the standard PTA. These correlations can be
difficult to interpret in isolation, and so the correlation seen
between frequencies in the standard range are also presented to
provide context. Additional summary statistics presented include
the coefficient of variation (CoV) which is the ratio of the stand-
ard deviation to the mean and provides a standardised measure of
dispersion to assess the variability of the FLFT measure with that
of standard audiometry. The lower the CoV, the more precise the
estimate of the underlying parameter. The root-mean-squared dif-
ference (RMSD) was also be used to quantify the reliability of the
FLFT method across the different runs at each intensity.
Results
Table 1 presents a summary of thresholds for the two approaches
at each frequency/intensity tested. The typical time taken to
acquire FLFT was 2min per run. The time taken to estimate
frequency thresholds at 70 dB was slightly longer than at 40 dB
and this was likely due to the starting frequency used. The effi-
ciency of the procedure could be increased by optimising the
step size and number of reversals.
Figure 2 shows the grand average (and 95% confidence inter-
vals) across the full cohort for both the PTA thresholds and
the FLFTs.
Correlations
Inspection of Table 2 indicates that there is a strong correlation
between the FLFT method of estimating high-frequency hearing
and the highest pure tone frequencies assessed (15,000 and
16,000Hz). For each FLFT level, there is a single summary met-
ric for each listener, which is the highest audible frequency at
that sound intensity. The values (in Hz) are averaged across the
Figure 1. Schematic showing the structure of trial presentation and response. Panel A shows the three intervals being visually cued over time. Panel B shows the
feedback given for a correct response and a summary of how the sound frequency for the next trial is changed based upon the responses of previous trials.
Table 1. Average thresholds across the two measurement methods are shown along with standard deviations and the coefficient of
variation for each measure.
Method Frequency/intensity Average threshold Standard deviation Coefficient of variation (%)
PTA 250 Hz 4.38 dB HL 6.81 dB HL 22.19
500 Hz 2.71 dB HL 5.00 dB HL 31.48
1000 Hz 4.38 dB HL 5.65 dB HL 48.59
2000 Hz 2.71 dB HL 5.77 dB HL 50.34
4000 Hz 1.46 dB HL 7.84 dB HL 59.48
8000 Hz 4.79 dB HL 8.84 dB HL 44.48
10000 Hz 7.08 dB HL 8.89 dB HL 35.49
12000 Hz 8.33 dB HL 13.20 dB HL 39.28
15102 Hz 20.63 dB HL 18.10 dB HL 30.50
16000 Hz 29.58 dB HL 17.97 dB HL 23.75
FLFT 40 dB SPL 14219 Hz 1472 Hz 10.74
70 dB SPL 16455 Hz 1607 Hz 10.71
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two runs and these values for each listener are correlated with
the PTA thresholds at each discrete frequency. The average FLFT
at 40 dB SPL was 14,101Hz and at 70 dB SPL was 16,349Hz.
These correlations are strong, which suggests the two methods of
characterising high-frequency hearing give comparable estimates
of how sensitive a listeners hearing is in the EHF range. The cor-
relation between FLFTs at the two levels was 0.66 (p< 0.001).
These correlations are potentially difficult to interpret as an
absolute value in isolation and so it is informative to consider
the strength of correlation between the different pure-tone fre-
quencies used for the standard assay of hearing (PTA). Table 3
shows the strength of correlation between each of the discrete
frequencies used for PTA in both the standard and EHF range.
Firstly, even for neighbouring frequencies, the correlations are in
general not as strong as those seen for FLFTs and the highest-
frequency pure tones used in the PTA assessment (15,000 and
16,000Hz). Secondly, there are only weak correlations across
PTA thresholds for the four EHFs (test frequencies above
8000Hz), which suggests that the relative fidelity of hearing
across the cohort of listeners would look different depending on
which PTA frequency was used. It must be noted that the num-
ber of participants with PTA thresholds greater than 20 dB HL
was, 1, 4, 9 and 15 at 1000Hz, 12,000Hz, 15,000Hz and
16,000Hz, respectively. Therefore the weak correlations will be
in part due to the fact that some participants’ hearing declines as
the frequency increases. However, it is also the case that some
people with poor thresholds at 12000Hz then have better hearing
thresholds at the higher frequencies.
Test–retest
The FLFT measure was performed twice at each SPL and it is,
therefore, possible to summarise the average difference between
the two. For the approach used here, the RMSD between the two
replications was 284Hz at 40 dB SPL and 176 Hz at 70 dB SPL,
which represents 2.01% and 1.08% of the mean, respectively.
Co-efficient of variation
The coefficient of variation for the FLFT method was 11% at
both presentation levels. The audiometric thresholds were first
converted from dB HL to dB SPL in order to be able to compute
a coefficient of variation. ISO 389-5 (2006) does not include val-
ues at 12,000 or 15,000Hz, but as the function describing the
relation between HL and SPL is predominantly linear between
10,000 and 16,000Hz, the values required were estimated via
interpolation. The coefficient of variation for the PTA approach
was, on average, 39% across the full frequency range. The lowest
value was 22% for 250Hz and the average for the standard and
EHF ranges were 43% and 32% respectively.
Discussion
The initial FLFT approach outlined by Rieke et al. (2017) was
shown to be quick and reliable in comparison with performing
standard PTA in the EHF range. The current implementation
demonstrated that it is possible to use the FLFT method of hearing
evaluation within a standard psychophysics framework and a
three-alternative forced-choice paradigm delivered via a PC. The
procedure remains as quick and as reliable as the initial implemen-
tation described by Rieke et al. (2017). The correlations indicate
that the FLFT approach yields a measure of hearing which agrees
with that obtained when using the highest frequencies available
with which to perform standard PTA. The test-retest descriptive
statistics reported in the current study compare favourably with
Rieke et al. (2017), who reported a RMSD of 400Hz in the
8,000–16,000Hz range (using an 80 dB SPL presentation level).
At the beginning of this article, we outlined three potential
problems with performing audiometry in the EHF range, the first
of which was how the test frequencies in the EHF range are
selected. A naive assumption, often implicit in our experiments
on normal-hearing listeners, is that someone with good hearing
at 1000Hz will also have better hearing at the other frequencies
Figure 2. Average thresholds (shown in dB SPL for ease of comparison) across
the full cohort are shown for the 6 frequencies tested in the conventional range
and the 4 EHFs using standard PTA methodology (circles). The squares denote
the average FLFTs at 40 and 70 dB SPL. Error bars show 95% confi-
dence intervals.
Table 2. Spearman correlation coefficients between standard PTA thresholds
(measured in dB HL) and FLFTs (measured in Hz) at 40 and 70 dB.
PTA Frequency (Hz)
FLFT Level (dB SPL)
40 70
250 0.26 0.32
500 0.29 0.27
1000 0.15 0.07
2000 0.06 0.09
4000 0.38 0.11
8000 0.61 0.28
10,000 0.42 0.13
12,000 0.47 0.05
15,000 0.72 0.68
16,000 0.75 0.79
n¼ 24. p 0.05; p 0.01; p 0.001.
Table 3. Spearman correlation coefficients across standard PTA thresholds
(dB HL).
PTA
Frequency (Hz) 500 1000 2000 4000 8000 10,00012,00015,000 16,000
250 0.700.34 0.04 0.02 0.44 0.28 0.27 0.18 0.11
500 0.770.42 0.44 0.580.27 0.01 0.32 0.18
1000 0.620.670.590.25 0.02 0.15 0.00
2000 0.63 0.25 0.26 0.03 0.07 0.10
4000 0.43 0.37 0.11 0.24 0.25
8000 0.47 0.40 0.48 0.32
10,000 0.53 0.20 0.16
12,000 0.39 0.35
15,000 0.89
n¼ 24. p 0.05; p 0.01; p 0.001.
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tested in the conventional range, compared to a listener with
poorer hearing at 1000Hz. Such an assumption is supported to
some degree by the correlations seen in Table 3 for the standard
audiometric frequencies (8000Hz and below). It can also be seen
in Table 3 that the strength of correlation is not as strong in the
EHF range; not even for frequencies which are the same number
of hertz apart from each other as for some of the standard audio-
metric frequencies. This does indicate that if a study were to only
select a single frequency to test, the choice of frequency would
have a deciding impact on the observed values. Though the FLFT
approach is still vulnerable to incorrectly characterising EHF hear-
ing due to an elevation at a specific frequency, this can be miti-
gated by performing an ascending and descending staircase to
ensure they converge. It is also quicker given that the FLFT roves
across the EHF range. A secondary, but still potentially limiting,
issue is the cost involved in purchasing a clinical system with EHF
capability or adding an extra module to an existing clinical system
to allow EHF thresholds to be measured. In short, it is much
more accessible and cost-effective to be able to use a standard PC
with an external soundcard and appropriate transducers.
The current study used an opportunity sample which consisted
of young people with clinically normal hearing yet still there were
4 missing data points when using PTA in the EHF range. By
replacing these values with the maximum system output þ5 dB
and þ10dB at 15,000Hz and 16,000Hz, respectively, which
reduces the accuracy of the data. If a study were to test more peo-
ple, people with a mild hearing loss, or people older than 40 then
this incidence of missing data points can only increase.
The specific level chosen at which to perform the FLFT meas-
urement can be informed by the specific population being tested.
If a study seeks to test young listeners with normal hearing, then
a quieter level would be preferable to loud level to ensure the
highest audible frequency is not near the limits of human hear-
ing or the maximum permissible frequency produced by the
hardware. Similarly, the level needs to be quiet enough such the
highest audible frequency does not simply give equivalent infor-
mation as standard PTA at 8000Hz. The measurement will then
yield a single number which characterises hearing in the EHF
range without the need to combine information across different
frequencies into a summary metric.
Summary
 FLFTs can be rapidly and reliably obtained using a standard
PC-soundcard-headphone setup.
 A single number is used to characterise the EHF sensitivity
of a listener.
 Provided the SPL of the tones is chosen appropriately, there
will be no missing data points; each participant will have a
measurable response.
 EHF thresholds can be obtained in all listeners without
needing to drive hardware to its limits and risk electrical
noise or transducer artefacts being detected by the listener.
Acknowledgements
This work was supported by the NIHR Manchester Biomedical
Research Centre.
Disclosure statement
No potential conflict of interest was reported by the author(s).
References
Bramhall, N. F., D. Konrad-Martin, G. P. McMillan, and S. E. Griest. 2017.
“Auditory Brainstem Response Altered in Humans with Noise Exposure
despite Normal Outer Hair Cell Function.” Ear and Hearing 38 (1):
e1–e12. doi:10.1097/AUD.0000000000000370.
British Society of Audiology. 2011. Pure-Tone Air-Conduction and Bone-
Conduction Threshold Audiometry with and without Masking. Reading,
UK: British Society of Audiology.
Fausti, S. A., J. A. Henry, W. J. Helt, D. S. Phillips, R. H. Frey, D.
Noffsinger, V. D. Larson, and C. G. Fowler. 1999. “An Individualized,
Sensitive Frequency Range for Early Detection of Ototoxicity.” Ear and
Hearing 20 (6): 497–505.
Grose, J. H., E. Buss, and J. W. Hall, 3rd. 2017. “Loud Music Exposure and
Cochlear Synaptopathy in Young Adults: Isolated Auditory Brainstem
Response Effects but No Perceptual Consequences.” Trends in Hearing 21:
1–18. doi:10.1177/2331216517737417.
Guest, H., K. J. Munro, G. Prendergast, S. Howe, and C. J. Plack. 2017.
“Tinnitus with a Normal Audiogram: Relation to Noise Exposure but No
Evidence for Cochlear Synaptopathy.” Hearing Research 344: 265–274. doi:
10.1016/j.heares.2016.12.002.
Hunter, L. L., B. B. Monson, D. R. Moore, S. Dhar, B. A. Wright, K. J.
Munro, L. M. Zadeh, C. M. Blankenship, S. M. Stiepan, and J. H. Siegel.
2020. “Extended High Frequency Hearing and Speech Perception
Implications in Adults and Children.” Hearing Research 10:7922.doi:10.
1016/j.heares.2020.107922.
Kennedy, I. C., B. M. Fitzharris, B. M. Colls, and C. H. Atkinson. 1990.
“Carboplatin is Ototoxic.” Cancer Chemotherapy and Pharmacology 26 (3):
232–234. doi:10.1007/BF02897206.
Liberman, M. C., M. J. Epstein, S. S. Cleveland, H. Wang, and S. F. Maison.
2016. “Toward a Differential Diagnosis of Hidden Hearing Loss in
Humans.” PLoS One 11 (9): e0162726. doi:10.1371/journal.pone.0162726.
Matz, G. J. 1993. “Aminoglycoside Cochlear Ototoxicity.” Otolaryngologic
Clinics of North America 26: 705–712.
Monson, B. B., J. Rock, A. Schulz, E. Hoffman, and E. Buss. 2019.
“Ecological Cocktail party listening reveals the utility of extended high-fre-
quency hearing.” Hearing Research 381: 107773. doi:10.1016/j.heares.2019.
107773.
Motlagh Zadeh, L., N. H. Silbert, K. Sternasty, D. W. Swanepoel, L. L.
Hunter, and D. R. Moore. 2019. “Extended High-Frequency Hearing
Enhances Speech Perception in Noise.” Proceedings of the National
Academy of Sciences 116 (47): 23753–23759. doi:10.1073/pnas.1903315116.
Prendergast, G., H. Guest, K. J. Munro, K. Kluk, A. Leger, D. A. Hall, M. G.
Heinz, and C. J. Plack. 2017. “Effects of Noise Exposure on Young Adults
with Normal Audiograms I: Electrophysiology.” Hearing Research 344:
68–81. doi:10.1016/j.heares.2016.10.028.
Prendergast, G., R. E. Millman, H. Guest, K. J. Munro, K. Kluk, R. S. Dewey,
D. A. Hall, M. G. Heinz, and C. J. Plack. 2017. “Effects of Noise Exposure
on Young Adults with Normal Audiograms II: Behavioral Measures.”
Hearing Research 356: 74–86. doi:10.1016/j.heares.2017.10.007.
Rieke, C. C., O. H. Clavier, L. V. Allen, A. P. Anderson, C. A. Brooks, A. M.
Fellows, D. S. Brungart, and J. C. Buckey. 2017. “Fixed-Level Frequency
Threshold Testing for Ototoxicity Monitoring.” Ear and Hearing 38 (6):
e369–e375. doi:10.1097/AUD.0000000000000433.
Schweitzer, V. G. 1993. “Ototoxicity of Chemotherapeutic Agents.”
Otolaryngologic Clinics of North America 26: 759–789.
INTERNATIONAL JOURNAL OF AUDIOLOGY 5
